Fresenius Medical Care AG & Co. KGaA (FMCQF)
FMCQF Stock Price Chart
Explore Fresenius Medical Care AG & Co. KGaA interactive price chart. Choose custom timeframes to analyze FMCQF price movements and trends.
FMCQF Company Profile
Discover essential business fundamentals and corporate details for Fresenius Medical Care AG & Co. KGaA (FMCQF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
7 Feb 2012
Employees
112.04K
CEO
Helen Giza
Description
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
FMCQF Financial Timeline
Browse a chronological timeline of Fresenius Medical Care AG & Co. KGaA corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 4 Nov 2025
Revenue estimate is $4.73B.
Earnings released on 5 Aug 2025
EPS came in at $0.90 falling short of the estimated $1.03 by -12.23%, while revenue for the quarter reached $5.64B , beating expectations by +12.88%.
Earnings released on 6 May 2025
EPS came in at $0.57 falling short of the estimated $0.81 by -30.50%, while revenue for the quarter reached $5.35B , beating expectations by +5.77%.
Earnings released on 25 Feb 2025
EPS came in at $0.24 falling short of the estimated $0.83 by -71.45%, while revenue for the quarter reached $5.27B , beating expectations by +13.10%.
Dividend declared on 4 Feb 2025
A dividend of $1.63 per share was announced, adjusted to $1.63. The dividend was paid on 27 May 2025.
Earnings released on 5 Nov 2024
EPS came in at $0.81 surpassing the estimated $0.79 by +2.53%, while revenue for the quarter reached $5.32B , missing expectations by -3.60%.
Earnings released on 30 Jul 2024
EPS came in at $0.69 falling short of the estimated $0.73 by -5.91%, while revenue for the quarter reached $5.13B , missing expectations by -3.79%.
Earnings released on 7 May 2024
EPS came in at $0.26 falling short of the estimated $0.59 by -56.04%, while revenue for the quarter reached $5.08B , beating expectations by +1.88%.
Earnings released on 12 Mar 2024
EPS came in at $0.70 falling short of the estimated $0.92 by -23.56%, while revenue for the quarter reached $5.49B , beating expectations by +0.12%.
Dividend declared on 9 Feb 2024
A dividend of $1.29 per share was announced, adjusted to $1.29. The dividend was paid on 22 May 2024.
Earnings released on 30 Sept 2023
EPS came in at $0.30 falling short of the estimated $0.57 by -47.18%, while revenue for the quarter reached $5.21B , beating expectations by +0.61%.
Earnings released on 30 Jun 2023
EPS came in at $0.52 falling short of the estimated $0.57 by -7.95%, while revenue for the quarter reached $5.26B , beating expectations by +1.29%.
Earnings released on 31 Mar 2023
EPS came in at $0.50 surpassing the estimated $0.48 by +2.86%, while revenue for the quarter reached $5.11B , beating expectations by +0.11%.
Dividend declared on 27 Feb 2023
A dividend of $1.21 per share was announced, adjusted to $1.22. The dividend was paid on 22 May 2023.
Earnings released on 21 Feb 2023
EPS came in at $0.86 surpassing the estimated $0.79 by +8.86%, while revenue for the quarter reached $5.38B , beating expectations by +0.73%.
Earnings released on 30 Oct 2022
EPS came in at $0.79 surpassing the estimated $0.68 by +16.18%, while revenue for the quarter reached $4.98B , beating expectations by +3.81%.
Earnings released on 28 Jul 2022
EPS came in at $0.77 falling short of the estimated $0.82 by -6.10%, while revenue for the quarter reached $4.98B , beating expectations by +0.89%.
Earnings released on 4 May 2022
EPS came in at $0.68 falling short of the estimated $0.69 by -1.45%, while revenue for the quarter reached $5.03B , beating expectations by +2.13%.
Earnings released on 22 Feb 2022
EPS came in at $0.90 surpassing the estimated $0.87 by +3.45%, while revenue for the quarter reached $5.27B , beating expectations by +0.98%.
Dividend declared on 22 Feb 2022
A dividend of $1.41 per share was announced, adjusted to $1.40. The dividend was paid on 17 May 2022.
Earnings released on 2 Nov 2021
EPS came in at $0.94 surpassing the estimated $0.91 by +3.30%, while revenue for the quarter reached $5.16B .
Earnings released on 30 Jul 2021
EPS came in at $0.76 surpassing the estimated $0.75 by +1.33%, while revenue for the quarter reached $5.13B .
Earnings released on 6 May 2021
EPS came in at $0.85 surpassing the estimated $0.80 by +6.25%, while revenue for the quarter reached $4.95B .
Dividend declared on 7 Apr 2021
A dividend of $1.63 per share was announced, adjusted to $1.64. The dividend was paid on 26 May 2021.
Earnings released on 23 Feb 2021
EPS came in at $1.27 surpassing the estimated $1.20 by +5.83%, while revenue for the quarter reached $5.40B .
Earnings released on 29 Oct 2020
EPS came in at $1.21 surpassing the estimated $1.15 by +5.22%, while revenue for the quarter reached $5.18B .
FMCQF Stock Performance
Access detailed FMCQF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.